|
Ralph Bobo, MD 
Medical Safety Officer
Executive Vice President,
Pharmacovigilance Reporting and Analysis
Dr. Ralph Bobo has nearly 20 years' experience in pharmaceutical clinical research, ten of which are at Sentrx. He has managed all phases of drug development as well as the development of safety reporting and tracking systems.
Prior to joining Sentrx, Dr. Bobo was Assistant Medical Director at Forest Laboratories. There he was an integral member of the team that submitted the Celexa NDA, writing and reviewing safety reports for the submission.
Dr. Bobo joined Sentrx in 1998 as Director of Medical Affairs, with responsibilities for all aspects of the Safety Response Center. During his tenure directing Pharmacovigilance Operations, Sentrx grew from 10 employees to nearly 70. As Executive Vice President of Phamacovigilance Practices, Dr. Bobo led the daily medical review of client cases and reports.
Dr. Bobo assumed his current position of Executive Vice President, Pharmacovigilance Reporting and Analysis, in February 2008. He is responsible for signal detection solution development and periodic reporting. Dr. Bobo continues to serve as the liaison between IT and Operations in the development of the SafetyTrak® Technology Suite and provides clinical support to the sales team.
Dr. Bobo received his degree from the Autonomous University of Guadalajara, School of Medicine, in Guadalajara, Mexico. |
